Skip to main content
Erschienen in:

11.04.2020

Promoting Colorectal Cancer Screening in South Asian Muslims Living in the USA

verfasst von: Eiman Kazi, Sadaf Sareshwala, Zahra Ansari, Dilpreet Sahota, Toshali Katyal, Winston Tseng, Susan L. Ivey

Erschienen in: Journal of Cancer Education | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Colorectal cancer is one of the more common forms of cancer in South Asian men and women. Despite the rates of colorectal cancer (CRC) in South Asians, the CRC screening rates remain low in South Asians and Muslims compared with those in Whites and other ethnic minorities in the USA. Religious and cultural barriers have been examined in relation to other types of cancer such as breast and cervical cancers. However, few data are available about CRC screening among Muslims, particularly South Asian American Muslims. A community-based participatory research approach was used to assess attitudes toward CRC screening and various cultural, religious, and gender barriers that prevent CRC screening expressed by Muslim South Asian men and women in the larger San Francisco Bay Area. Six focus groups were conducted (three males and three females) with South Asian American Muslims. The focus groups consisted of a total sample size of n = 32, with 15 men and 17 women, with the average age of participants being 57 years old. This study highlighted key religious, cultural, and gender barriers to CRC screening including lack of awareness of CRC, the notion of fatalism as it relates to screening, lack of emphasis on preventive health, the need to preserve modesty, and stigma around certain CRC screening practices. Religiously tailored interventions and culturally sensitive healthcare providers are needed to better promote CRC screening in South Asian Muslim communities and to help inform the design of health interventions and outreach strategies.
Literatur
3.
Zurück zum Zitat Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte S, Etzioni R, McKenna M, Oeffinger KC, Shih YT, Walter LC, Andrews KS, Brawley OW, Brooks D, Fedewa SA, Manassaram-Baptiste D, Siegel RL, Wender RC, Smith RA (2018) Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 68:250–281. https://doi.org/10.3322/caac.21457CrossRefPubMed Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte S, Etzioni R, McKenna M, Oeffinger KC, Shih YT, Walter LC, Andrews KS, Brawley OW, Brooks D, Fedewa SA, Manassaram-Baptiste D, Siegel RL, Wender RC, Smith RA (2018) Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 68:250–281. https://​doi.​org/​10.​3322/​caac.​21457CrossRefPubMed
6.
Zurück zum Zitat Shiekh NA, Mir MA (2016) The framing of SAARC development goals: South Asia’s response to millennium development goals. Int J Appl Eng Res 2(1):570–575 Shiekh NA, Mir MA (2016) The framing of SAARC development goals: South Asia’s response to millennium development goals. Int J Appl Eng Res 2(1):570–575
7.
Zurück zum Zitat Das Gupta M, Gupta C, Teaiwa KM (2007) Rethinking South Asian diaspora studies. Cult Dyn 19:125–140CrossRef Das Gupta M, Gupta C, Teaiwa KM (2007) Rethinking South Asian diaspora studies. Cult Dyn 19:125–140CrossRef
8.
12.
14.
Zurück zum Zitat Ponce NA, Tseng W, Ong P, et al (2009) The state of Asian American, Native Hawaiian and Pacific Islander Health in California report Ponce NA, Tseng W, Ong P, et al (2009) The state of Asian American, Native Hawaiian and Pacific Islander Health in California report
15.
Zurück zum Zitat Ivey SL, Mehta KM, Fyr CLW, Kanaya AM (2006) Prevalence and correlates of cardiovascular risk factors in South Asians: population-based data from two California surveys. Ethn Dis 16:886–893 Ivey SL, Mehta KM, Fyr CLW, Kanaya AM (2006) Prevalence and correlates of cardiovascular risk factors in South Asians: population-based data from two California surveys. Ethn Dis 16:886–893
16.
Zurück zum Zitat Palaniappan L, Mukherjea A, Holland A, Ivey SL (2010) Leading causes of mortality of Asian Indians in California. Ethn Dis 20:53–57PubMed Palaniappan L, Mukherjea A, Holland A, Ivey SL (2010) Leading causes of mortality of Asian Indians in California. Ethn Dis 20:53–57PubMed
25.
Zurück zum Zitat Underwood SM, Shaikha L, Bakr D (1999) Veiled yet vulnerable. Breast cancer screening and the Muslim way of life. Cancer Pract 7:285–290CrossRef Underwood SM, Shaikha L, Bakr D (1999) Veiled yet vulnerable. Breast cancer screening and the Muslim way of life. Cancer Pract 7:285–290CrossRef
38.
Zurück zum Zitat Padela AI, Malik S, Vu M et al (2018) Developing religiously-tailored health messages for behavioral change: introducing the reframe, reprioritize, and reform (“3R”) model. Soc Sci Med 204:92–99CrossRef Padela AI, Malik S, Vu M et al (2018) Developing religiously-tailored health messages for behavioral change: introducing the reframe, reprioritize, and reform (“3R”) model. Soc Sci Med 204:92–99CrossRef
Metadaten
Titel
Promoting Colorectal Cancer Screening in South Asian Muslims Living in the USA
verfasst von
Eiman Kazi
Sadaf Sareshwala
Zahra Ansari
Dilpreet Sahota
Toshali Katyal
Winston Tseng
Susan L. Ivey
Publikationsdatum
11.04.2020
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 4/2021
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-020-01715-3

Neu im Fachgebiet Onkologie

Körperlich fitte Krebskranke leben länger

Krebspatienten, auch und vor allem solche in fortgeschrittenen Stadien, profitieren offenbar von guter körperlicher Verfassung. Hohe Muskelkraft und kardiorespiratorische Fitness sind laut Ergebnissen einer Metaanalyse mit geringerer Mortalität assoziiert.

Kein (großer) Schutz vor Kolorektalkarzinom-Rezidiven durch ASS

Die erste Phase-3-Studie zum Nutzen von ASS in der adjuvanten Therapie des kolorektalen Karzinoms ist negativ verlaufen. Das abschließende Urteil über eine Sekundärprävention mit ASS ist trotzdem noch nicht gefallen.

Frühe CLL-Therapie: BTK-Hemmer verlängert EFS und PFS, aber nicht OS

Auch nach sechs Jahren ergibt sich kein Überlebensvorteil einer Therapie mit dem BTK-Hemmer Ibrutinib für Menschen mit frühem CLL-Stadium und erhöhtem Progressionsrisiko. Die Progressionsrate wird mit der Behandlung jedoch um über 80% gesenkt.

Adjuvantes Atezolizumab ohne Nutzen bei frühem TNBC

Patientinnen mit frühem triple-negativem Brustkrebs profitieren nach der Operation offenbar nicht von einer Zugabe des PD-L1-Hemmers Atezolizumab zur adjuvanten Standardchemotherapie. Die Studie, die das untersucht hat, wurde vorzeitig abgebrochen. Was könnte die schlechte Wirksamkeit erklären?

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.